Alex Shteynshlyuger

    • Media Contact:
      Alex Shteynslyuger
    • Member Type(s): Expert
    • Title:Director of Urology; Urologist
    • Organization:New York Urology Specialists
    • Area of Expertise:urology, prostate cancer, bladder cancer

    To become a ProfNet premium member and receive requests from reporters looking for expert sources, click here.

My Expertise

    My Expertise

      Area(s) of expertise: urology, prostate cancer, bladder cancer
      Summary of expertise:
      Dr. Alex Shteynshlyuger is a board certified urologic surgeon. He is fellowship trained in Urologic Oncology and Endourology.

      Dr. Shteynshlyuger has extensive experience of treating complex urological conditions including all stages of prostate cancer, bladder cancer, renal cancer and complicated kidney stones.

      He embraces multimodal treatments for urological conditions that include medical and surgical treatment, as well as chemotherapy, immunotherapy and radiation therapy when necessary. He is keen on having patients counseled about dietary and behavioral changes for prevention and treatment of urological conditions. He uses evidence based medicine, and draws on high quality research including randomized controlled studies, to optimize care for his patients.

      He is particularly interested in maximizing quality of life for patients with urological conditions.

      His research has been presented at national meetings.
      Blog/Web site:
      White paper/research:
      In addition to being recognized for his clinical acumen, Dr. Shteynshlyyuger is an accomplished surgeon-scientist with multiple scientific publications and presentations to his name.

      With background in healthcare, molecular biology, economics and information technology he possesses a unique analytical skill set that sets him apart as a key opinion leader on innovation in healthcare.

      Alex Shteynshlyuger, MD is interested in optimizing healthcare delivery through efficient utilization of resources, alignment of incentives among stakeholders and improving the balance between efficacy and safety in healthcare.

      He is involved in health economics outcomes research including quality of life studies. His research has been recognized nationally and has been quoted by highly respected organizations including the Prostate Cancer Foundation, the US Preventive Services Task Force (USPSTF), and multiple professional guidelines.

      Books/articles published:
      Kathy L. Schulman, MA, Karina Berenson, MPH, Ya-Chen (Tina) Shih, PhD, Kathleen A. Foley, PhD, Arijit Ganguli, MBA, PhD, Jonas de Souza MD, Alex Shteynshlyuger, MD. “A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report Of The ISPOR Oncology Good Outcomes Research Practices Working Group.” Value in Health 16 (2013): 655-669.

      Shteynshlyuger A, Yu J. “Familial testicular torsion: A meta analysis suggests inheritance.” J Pediatr Urol. 2012 Sep 24.

      Shteynshlyuger A, Andriole GL. "Cost Effectiveness of PSA Screening in the US: Extrapolating from the ERSPC Trial". J. Urology. Vol 185. P828-832: March 2011.

      Shteynshlyuger A, Freyle, J. “Familial Testicular Torsion in Three Consecutive Generations of First Degree Relatives.” J Pediatr Urol. 2011 Feb;7(1):86-91

      Shteynshlyuger A, Andriole GL. “Prostate cancer: to screen or not to screen?” in Advances and Controversies in Prostate Cancer, An Issue of Urologic Clinics By William K.

      Dr. Shteynshlyuger is board certified with the American
      Board of Urology.

      He is a member of the American Urological Association, Society of Urologic Oncology, American Society for Clinical Oncology (ASCO) and AMA.

      His many honors and awards include:

      2010 Ambrose/Reed Socioeconomics Prize Essay Contest – Winner - sponsored by the AUA (American Urologic Association): "Cost Effectiveness of PSA Screening in the US: Extrapolating from the ERSPC Trial". Recognized during the annual AUA Health Policy Council Breakfast (May 31, 2010 - San Francisco AUA Meeting).

      Chief Residents’Debate - Winner. “Ureteroscopic laser lithotripsy vs Flomax/observation.” Section of Urology. The New York Academy of Medicine. Wednesday, March 4th , 2009.

      Best Resident Research Paper – Greater Maimonides Scientific Day – “Genitourinary tuberculosis as the primary manifestation of infection. A new paradigm of tuberculosis epidemiology.” May 9, 2007.

      Howard Hughes Fellow in Bi

      Educational background:
      Washington University in St Louis / Barnes-Jewish Hospital
      SUNY Downstate School of Medicine
      Brandeis University
      Networking, healthcare improvement and care optimization.

Profile TagsPlease separate tags with commas

    This user's friends are private.